Drugs & TargetsFree Lynparza approved in the EU as first-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer November 06, 2020Vol.46 No.42
Drugs & TargetsFree Kymriah receives approval for commercial manufacturing in Japan November 06, 2020Vol.46 No.42
Clinical RoundupFree Cancer patients, clinicians find value in electronic real-time symptom reporting November 06, 2020Vol.46 No.42
Clinical RoundupFree Colon cancer surgery performed by highly skilled surgeons improves long-term survival for patients November 06, 2020Vol.46 No.42
Clinical RoundupFree Active surveillance is safe for African Americans with low-risk prostate cancer November 06, 2020Vol.46 No.42
Clinical RoundupFree Nerves keep pancreatic cancer cells from starving, study finds November 06, 2020Vol.46 No.42
Clinical RoundupFree Large-scale cancer proteomics study profiles protein changes in response to drug treatments November 06, 2020Vol.46 No.42
FreeTrials & Tribulations Living with cannabis: The goal of helping cancer patients live in comfort deserves data now November 06, 2020Vol.46 No.42By Dylan M. Zylla
